Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.22 | $7,121.75 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,583 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,000 | $71.22 | $71,215.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,683 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,125 | $71.21 | $151,321.25 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,683 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,200 | $71.20 | $156,640.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,808 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $71.20 | $21,359.25 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,008 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,782 | $71.19 | $126,860.58 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,308 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $71.19 | $21,355.50 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,090 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 818 | $71.18 | $58,225.24 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,390 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,000 | $71.17 | $71,170.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,208 Read SEC document |
| June 03, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 8,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,187 Read SEC document |
| June 03, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 28 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By child Disclosed balance after: 450 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| June 03, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 2,250 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 175,477 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · derivative · entry 30 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,953 Underlying: Common stock · 175,477 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 400 | $64.74 | $25,895.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 29 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,660 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 900 | $64.74 | $58,261.50 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 28 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,060 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 4,000 | $64.73 | $258,920.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,960 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,400 | $64.73 | $90,615.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,960 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $64.72 | $19,414.50 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 24 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,354 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 8,100 | $64.71 | $524,151.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 23 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,654 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,100 | $64.71 | $71,175.50 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 22 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 576,754 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 34,900 | $64.70 | $2,258,030.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 21 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,854 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 400 | $64.70 | $25,878.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 20 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,754 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,200 | $64.69 | $207,008.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,154 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,805 | $64.69 | $116,756.43 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,354 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 4,317 | $64.68 | $279,223.56 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,159 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,500 | $64.67 | $161,675.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,476 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,800 | $64.66 | $245,708.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,976 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $64.66 | $12,931.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,776 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 8,100 | $64.65 | $523,665.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,976 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,000 | $64.64 | $193,920.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,076 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 900 | $64.62 | $58,158.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,076 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,548 | $64.61 | $229,236.28 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,976 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 5,600 | $64.60 | $361,760.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644,524 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 800 | $64.59 | $51,672.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,124 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $64.58 | $19,374.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,924 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,300 | $64.57 | $83,941.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 651,224 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,100 | $64.56 | $135,576.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,524 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 400 | $64.53 | $25,812.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,624 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 800 | $64.52 | $51,616.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,024 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,800 | $64.50 | $116,100.00 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,824 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:01 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 175,477 | $35.88 | $6,296,114.76 |
DisclosureSEC source: 0001179110-15-006874 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 657,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,969 | $64.89 | $192,658.41 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 28 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,428 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $64.88 | $12,976.50 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,397 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,800 | $64.88 | $116,784.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,597 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,000 | $64.88 | $64,875.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 25 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,397 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $64.87 | $6,486.75 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 23 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,697 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 3,100 | $64.87 | $201,081.50 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 22 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,797 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 14,000 | $64.86 | $908,040.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 21 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,897 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 800 | $64.86 | $51,886.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 20 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,897 Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 18:02 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,869 | $64.86 | $121,214.00 |
DisclosureSEC source: 0001179110-15-006875 · edgar.xml · nonDerivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,697 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.